Connection

Allen Kaplan to Histamine Release

Back to Details
This is a "connection" page, showing publications Allen Kaplan has written about Histamine Release.
Allen Kaplan
Connection Strength
3.078
Histamine Release
  1. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003 Aug; 58(8):802-7.
    View in: PubMed
    Score: 0.214
  2. Diagnosis and treatment of chronic spontaneous urticaria. Allergy. 2020 07; 75(7):1830-1832.
    View in: PubMed
    Score: 0.168
  3. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol. 1999 Jul; 104(1):169-72.
    View in: PubMed
    Score: 0.161
  4. Basophil histamine release in patients with chronic spontaneous urticaria: Optimize or minimize. J Allergy Clin Immunol. 2019 08; 144(2):622-623.
    View in: PubMed
    Score: 0.160
  5. Further characterization of histamine releasing chemokines present in fractionated supernatants derived from human mononuclear cells. Clin Exp Allergy. 1996 Aug; 26(8):926-33.
    View in: PubMed
    Score: 0.131
  6. Relationship of histamine-releasing factors and histamine-releasing inhibitory factors to chemokine group of cytokine. Allergy Asthma Proc. 1996 Jan-Feb; 17(1):5-11.
    View in: PubMed
    Score: 0.126
  7. Chemokines as allergic mediators--relationship to histamine-releasing factors. Allergy. 1994 Aug; 49(7):495-501.
    View in: PubMed
    Score: 0.114
  8. Characterization of the human basophil response to cytokines, growth factors, and histamine releasing factors of the intercrine/chemokine family. J Immunol. 1993 Mar 01; 150(5):1932-43.
    View in: PubMed
    Score: 0.104
  9. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils. J Immunol. 1992 Jul 15; 149(2):636-42.
    View in: PubMed
    Score: 0.099
  10. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol. 1992 Mar; 89(3):666-72.
    View in: PubMed
    Score: 0.097
  11. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992 Feb 01; 175(2):489-93.
    View in: PubMed
    Score: 0.096
  12. Cytokine stimulation of human basophil histamine release. Immunol Ser. 1992; 57:573-86.
    View in: PubMed
    Score: 0.096
  13. IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol. 1991 Sep 15; 147(6):1920-4.
    View in: PubMed
    Score: 0.094
  14. Histamine releasing factors. Clin Exp Allergy. 1991 Jan; 21 Suppl 1:8-16.
    View in: PubMed
    Score: 0.089
  15. Histamine-releasing factors. Int Arch Allergy Appl Immunol. 1991; 94(1-4):148-53.
    View in: PubMed
    Score: 0.089
  16. Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest. 1990 May; 85(5):1516-21.
    View in: PubMed
    Score: 0.085
  17. Purification and further characterization of human mononuclear cell histamine-releasing factor. J Clin Invest. 1989 Apr; 83(4):1204-10.
    View in: PubMed
    Score: 0.079
  18. Responsiveness to human mononuclear cell-derived histamine-releasing factor. Studies of allergic status and the role of IgE. J Immunol. 1988 Oct 15; 141(8):2688-92.
    View in: PubMed
    Score: 0.077
  19. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
    View in: PubMed
    Score: 0.076
  20. Human recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3 cause basophil histamine release. J Clin Invest. 1988 Jul; 82(1):17-20.
    View in: PubMed
    Score: 0.075
  21. Chronic urticaria: what is new, where are we headed. Allergol Immunopathol (Madr). 2007 Mar-Apr; 35(2):57-61.
    View in: PubMed
    Score: 0.068
  22. Characterization and functional studies of rheumatoid synovial mast cells. Activation by secretagogues, anti-IgE, and a histamine-releasing lymphokine. Arthritis Rheum. 1986 Aug; 29(8):944-55.
    View in: PubMed
    Score: 0.066
  23. Effects of calcineurin inhibitors on an in vitro assay for chronic urticaria. Clin Exp Allergy. 2005 May; 35(5):554-9.
    View in: PubMed
    Score: 0.060
  24. Functional assessment of pathogenic IgG subclasses in chronic autoimmune urticaria. J Allergy Clin Immunol. 2005 Apr; 115(4):815-21.
    View in: PubMed
    Score: 0.060
  25. Assessment of histamine release and kinin formation in man: identification of kinin degradation products and characterization of a lymphocyte-dependent histamine releasing factor. Int Arch Allergy Appl Immunol. 1985; 77(1-2):64-8.
    View in: PubMed
    Score: 0.059
  26. Comments regarding 'Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells' by Asero et al. A.P. Kaplan. Clin Exp Allergy. 2004 Nov; 34(11):1803; author reply 1804-5.
    View in: PubMed
    Score: 0.058
  27. A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. J Allergy Clin Immunol. 2002 Jan; 109(1):114-8.
    View in: PubMed
    Score: 0.048
  28. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981 Oct 29; 305(18):1074-7.
    View in: PubMed
    Score: 0.047
  29. Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 1981 Aug; 68(2):103-5.
    View in: PubMed
    Score: 0.046
  30. Comparative studies of functional and binding assays for IgG anti-Fc(epsilon)RIalpha (alpha-subunit) in chronic urticaria. J Allergy Clin Immunol. 1998 May; 101(5):672-6.
    View in: PubMed
    Score: 0.037
  31. Assessment of autoimmunity in patients with chronic urticaria. J Allergy Clin Immunol. 1997 Apr; 99(4):461-5.
    View in: PubMed
    Score: 0.034
  32. Mediator release from basophil granulocytes in chronic myelogenous leukemia. J Allergy Clin Immunol. 1976 Dec; 58(6):623-34.
    View in: PubMed
    Score: 0.034
  33. Effects of PBMC-derived histamine-releasing factors on histamine release from human skin and lung mast cells. Clin Exp Allergy. 1995 Sep; 25(9):890-5.
    View in: PubMed
    Score: 0.031
  34. Chemokines and the allergic response. Exp Dermatol. 1995 Aug; 4(4 Pt 2):260-5.
    View in: PubMed
    Score: 0.031
  35. Chemokines of the alpha, beta-subclass inhibit human basophils' responsiveness to monocyte chemotactic and activating factor/monocyte chemoattractant protein-1. J Allergy Clin Immunol. 1995 Feb; 95(2):574-86.
    View in: PubMed
    Score: 0.030
  36. Histamine releasing factors and cytokine-dependent activation of basophils and mast cells. Adv Immunol. 1991; 50:237-60.
    View in: PubMed
    Score: 0.022
  37. Neutrophils and mast cells. Comparison of neutrophil-derived histamine-releasing activity with other histamine-releasing factors. J Immunol. 1988 Nov 15; 141(10):3575-83.
    View in: PubMed
    Score: 0.019
  38. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988 Feb; 90(2):213-7.
    View in: PubMed
    Score: 0.018
  39. Increased responsiveness of basophils of patients with chronic urticaria to sera but hypo-responsiveness to other stimuli. Clin Exp Allergy. 2005 Apr; 35(4):456-60.
    View in: PubMed
    Score: 0.015
  40. Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984 Apr; 73(4):453-6.
    View in: PubMed
    Score: 0.014
  41. Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol. 1981 Oct; 68(4):319-24.
    View in: PubMed
    Score: 0.012
  42. The physical urticarias. Int J Dermatol. 1980 Oct; 19(8):417-35.
    View in: PubMed
    Score: 0.011
  43. Evaluation of a patient with cold and cholinergic urticaria. J Allergy Clin Immunol. 1979 Jan; 63(1):35-8.
    View in: PubMed
    Score: 0.010
  44. Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity. J Allergy Clin Immunol. 1976 Jun; 57(6):605-8.
    View in: PubMed
    Score: 0.008
  45. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975 Jun; 55(6):394-402.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.